Artificial Intelligence Review,
Journal Year:
2025,
Volume and Issue:
58(3)
Published: Jan. 17, 2025
Edge
deep
learning,
a
paradigm
change
reconciling
edge
computing
and
facilitates
real-time
decision
making
attuned
to
environmental
factors
through
the
close
integration
of
computational
resources
data
sources.
Here
we
provide
comprehensive
review
current
state
art
in
focusing
on
computer
vision
applications,
particular
medical
diagnostics.
An
overview
foundational
principles
technical
advantages
learning
is
presented,
emphasising
capacity
this
technology
revolutionise
wide
range
domains.
Furthermore,
present
novel
categorisation
hardware
platforms
based
performance
usage
scenarios,
facilitating
platform
selection
operational
effectiveness.
Following
this,
dive
into
approaches
effectively
implement
neural
networks
devices,
encompassing
methods
such
as
lightweight
design
model
compression.
Reviewing
practical
applications
fields
general
diagnostics
particular,
demonstrate
profound
impact
edge-deployed
models
can
have
real-life
situations.
Finally,
an
analysis
potential
future
directions
obstacles
adoption
with
intention
stimulate
further
investigations
advancements
intelligent
solutions.
This
survey
provides
researchers
practitioners
reference
shedding
light
critical
role
plays
advancement
applications.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 8, 2025
Abstract
Cancer
is
a
major
global
health
challenge,
with
approximately
19.3
million
new
cases
and
10
deaths
estimated
by
2020.
Laboratory
advancements
in
cancer
detection
have
transformed
diagnostic
capabilities,
particularly
through
the
use
of
biomarkers
that
play
crucial
roles
risk
assessment,
therapy
selection,
disease
monitoring.
Tumor
histology,
single-cell
technology,
flow
cytometry,
molecular
imaging,
liquid
biopsy,
immunoassays,
diagnostics
emerged
as
pivotal
tools
for
detection.
The
integration
artificial
intelligence,
deep
learning
convolutional
neural
networks,
has
enhanced
accuracy
data
analysis
capabilities.
However,
developing
countries
face
significant
challenges
including
financial
constraints,
inadequate
healthcare
infrastructure,
limited
access
to
advanced
technologies.
impact
COVID-19
further
complicated
management
resource-limited
settings.
Future
research
should
focus
on
precision
medicine
early
diagnosis
sophisticated
laboratory
techniques
improve
prognosis
outcomes.
This
review
examines
evolving
landscape
detection,
focusing
breakthroughs
limitations
countries,
while
providing
recommendations
advancing
tumor
resource-constrained
environments.
Journal of Imaging,
Journal Year:
2025,
Volume and Issue:
11(2), P. 59 - 59
Published: Feb. 15, 2025
Artificial
intelligence
(AI)
transforms
image
data
analysis
across
many
biomedical
fields,
such
as
cell
biology,
radiology,
pathology,
cancer
and
immunology,
with
object
detection,
feature
extraction,
classification,
segmentation
applications.
Advancements
in
deep
learning
(DL)
research
have
been
a
critical
factor
advancing
computer
techniques
for
mining.
A
significant
improvement
the
accuracy
of
detection
algorithms
has
achieved
result
emergence
open-source
software
innovative
neural
network
architectures.
Automated
now
enables
extraction
quantifiable
cellular
spatial
features
from
microscope
images
cells
tissues,
providing
insights
into
organization
various
diseases.
This
review
aims
to
examine
latest
AI
DL
mining
microscopy
images,
aid
biologists
who
less
background
knowledge
machine
(ML),
incorporate
ML
models
focus
images.
Frontiers in Computational Neuroscience,
Journal Year:
2024,
Volume and Issue:
18
Published: June 12, 2024
The
necessity
of
prompt
and
accurate
brain
tumor
diagnosis
is
unquestionable
for
optimizing
treatment
strategies
patient
prognoses.
Traditional
reliance
on
Magnetic
Resonance
Imaging
(MRI)
analysis,
contingent
upon
expert
interpretation,
grapples
with
challenges
such
as
time-intensive
processes
susceptibility
to
human
error.
Cancer
is
one
of
the
leading
causes
death,
making
timely
diagnosis
and
prognosis
very
important.
Utilization
AI
(artificial
intelligence)
enables
providers
to
organize
process
patient
data
in
a
way
that
can
lead
better
overall
outcomes.
This
review
paper
aims
look
at
varying
uses
for
clinical
utility.
PubMed
EBSCO
databases
were
utilized
finding
publications
from
January
1,
2013,
December
22,
2023.
Articles
collected
using
key
search
terms
such
as
“artificial
intelligence”
“machine
learning.”
Included
collection
studies
application
determining
cancer
multi-omics
data,
radiomics,
pathomics,
laboratory
data.
The
resulting
89
categorized
into
eight
sections
based
on
type
then
further
subdivided
two
subsections
focusing
prognosis,
respectively.
8
integrated
more
than
form
omics,
namely
genomics,
transcriptomics,
epigenomics,
proteomics.
Incorporating
alongside
omics
represents
significant
advancement.
Given
considerable
potential
this
domain,
ongoing
prospective
are
essential
enhance
algorithm
interpretability
ensure
safe
integration.
Oral Oncology Reports,
Journal Year:
2024,
Volume and Issue:
11, P. 100591 - 100591
Published: June 29, 2024
Artificial
intelligence
(AI)
has
emerged
as
a
promising
tool
in
oral
oncology,
particularly
the
field
of
prediction.
This
review
provides
comprehensive
outlook
on
role
AI
predicting
cancer,
covering
key
aspects
such
data
collection
and
preprocessing,
machine
learning
techniques,
performance
evaluation
validation,
challenges,
future
prospects,
implications
for
clinical
practice.
Various
algorithms,
including
supervised
learning,
unsupervised
deep
approaches,
have
been
discussed
context
cancer
Additionally,
challenges
interpretability,
accessibility,
regulatory
compliance,
legal
are
addressed
along
with
research
directions
potential
impact
oncology
care.
Communications Medicine,
Journal Year:
2024,
Volume and Issue:
4(1)
Published: Oct. 17, 2024
In
the
era
of
personalized
cancer
treatment,
understanding
intrinsic
heterogeneity
tumors
is
crucial.
Despite
some
patients
responding
favorably
to
a
particular
others
may
not
benefit,
leading
varied
efficacy
observed
in
standard
therapies.
This
study
focuses
on
prediction
tumor
response
chemo-immunotherapy,
exploring
potential
mechanics
and
medical
imaging
as
predictive
biomarkers.
We
have
extensively
studied
"desmoplastic"
tumors,
characterized
by
dense
very
stiff
stroma,
which
presents
substantial
challenge
for
treatment.
The
increased
stiffness
such
can
be
restored
through
pharmacological
intervention
with
mechanotherapeutics.
developed
deep
learning
methodology
based
shear
wave
elastography
(SWE)
images,
involved
convolutional
neural
network
(CNN)
model
enhanced
attention
modules.
was
evaluated
biomarker
setting
detecting
responsive,
stable,
non-responsive
chemotherapy,
immunotherapy,
or
combination,
following
mechanotherapeutics
administration.
A
dataset
1365
SWE
images
obtained
from
630
our
previous
experiments
used
train
successfully
evaluate
methodology.
combination
models,
has
demonstrated
promising
results
disease
diagnosis
classification
but
their
predicting
prior
therapy
yet
fully
realized.
present
strong
evidence
that
integrating
SWE-derived
biomarkers
automatic
segmentation
algorithms
enables
accurate
detection
therapeutic
outcomes.
approach
enhance
treatment
providing
non-invasive,
reliable
predictions
Voutouri,
Englezos
et
al.
utilizing
ultrasound
chemo-immunotherapy
responses
mouse
tumors.
Through
training
optimization
large
number
this
highlights
combining
it
important
understand
all
respond
same
way
therapy.
While
benefit
not,
different
how
will
chemotherapy
immunotherapy.
Specifically,
we
looked
at
difficult-to-treat
structures.
These
softened
certain
drugs
making
them
more
responsive
computer
method
analyze
measure
Our
trained
set
able
predict
well
would
Overall,
could
improve
using
non-invasive
therapies
most
effective
each
patient.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(22), P. 3791 - 3791
Published: Nov. 11, 2024
Lung
and
colon
cancers
are
among
the
most
prevalent
lethal
malignancies
worldwide,
underscoring
urgent
need
for
advanced
diagnostic
methodologies.
This
study
aims
to
develop
a
hybrid
deep
learning
machine
framework
classification
of
Colon
Adenocarcinoma,
Benign
Tissue,
Squamous
Cell
Carcinoma
from
histopathological
images.